Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Chinese Journal of Rehabilitation Theory and Practice ; (12): 6-9, 2019.
Article in Chinese | WPRIM | ID: wpr-744563

ABSTRACT

Objective To explore the assessment and classification for children aged 6-18 with severe intellectual disability.Methods A total of 36 children with severe intellectual disability were assessed with Wechsler Preschool and Primacy Scale of Intelligence (WPPSI-Ⅳ) (CN) and Adaptive Behavior Assessment System (ABAS-Ⅱ) (CNC).Results The ratio intelligence quotient of WPPSI-Ⅳ was (32.4±4.91), consistent with the results from ABAS-Ⅱ.Conclusion WPPSI-Ⅳ and ABAS-Ⅱ can be used for assessment and classification of severity of intellectual disability for children aged 6-18 and intelligence quotient less than 45.

2.
Chinese Traditional and Herbal Drugs ; (24): 1141-1144, 2019.
Article in Chinese | WPRIM | ID: wpr-851303

ABSTRACT

Objective To prepare hydrophobic chitosan from Catharsius molossus and study its hemostatic effect. Methods The chitosan from C. molossus was used as material to carry out hydrophobic modification and characterization by acylation with lauric anhydride. At the same time, the hemostatic effect was studied by in vitro agglutination test and mouse liver wound experiment. Results The prepared hydrophobic chitosan had a hydrophobic group substitution degree of (11.69 ± 0.14)%, which was higher than that of commercially available hydrophobic chitosan. The in vitro agglutination experiment showed that it could coagulate in (3.42 ± 0.39) s when mixed with blood at a concentration of 6.0 mg/g, which was better than chitosan and hydrophobically modified commercial chitosan. The mouse liver wound experiment showed that chitosan from C. molossus could shorten hemostatic time significantly compared with chitosan and hydrophobically modified commercial chitosan. Conclusion Hydrophobically modified chitosan can significantly improve the coagulation performance of chitosan, and the hydrophobic chitosan from C. molossus is excellent, and it is expected to be a new hemostatic material with great potential.

3.
Journal of Experimental Hematology ; (6): 1649-1655, 2014.
Article in English | WPRIM | ID: wpr-340442

ABSTRACT

This study was purposed to evaluate whether the safe concentration of magnetic nanoparticles of Fe₃O₄(MNPs-Fe₃O₄) for monocytes could induce the SKM-1 cell apoptosis. The average size and Zeta potential of MNPs-Fe₃O₄were determined by transmission electron microscopy and the Malvern Zetasizer 3000 HS, respectively. The cell viability after being exposed to MNPs-Fe₃O₄for 12, 24, 48, and 72 hours was detected by using cell count Kit-8. The cell apoptosis was evaluated by flow cytometry with Annexin V/PI double staining and Wright-Giemsa staining. The cell cycle was measured by flow cytometry. The levels of active caspase-3, survivin and bcl-rambo in cells treated with MNPs-Fe₃O₄and/or trolox for 48 hours were detected with Western blot. The results showed that the cell viability decreased in SKM-1 cells after exposure to 50 µmol/L and 100 µmol/L MNPs-Fe₃O₄(P < 0.05), but did not in monocytes (P > 0.05), compared with that of each non-MNPs-Fe₃O₄-treated group. This exposure also induced the SKM-1 cells to be arrested in G0/G1. Annexin V/PI staining assay showed that cell apoptotic rate induced by 100 µmol/L MNPs-Fe₃O₄was significantly high in SKM-1 cells while not so high in monocytes, and the pretreatment with trolox could attenuate the apoptosis. Moreover, the active caspase-3 increased in SKM-1 cells after the exposure to MNPs-Fe₃O₄, while that was not in monocytes, and the increased expression of BCL-rambo and the decreased expression of survivin involved in the process were also observed. It is concluded that MNPs-Fe₃O₄can induce the caspase 3-dependent SKM-1 cell apoptosis by increasing the BCL-rambo expression and decreasing the survivin expression, but this cytotoxic effect can not be observed in monocyte's.


Subject(s)
Humans , Apoptosis , Caspase 3 , Cell Cycle , Cell Line, Tumor , Ferric Compounds , Pharmacology , Flow Cytometry , Magnetics , Metal Nanoparticles
4.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 351-353, 2009.
Article in Chinese | WPRIM | ID: wpr-337506

ABSTRACT

<p><b>OBJECTIVE</b>To observe the clinical effect of integrative medicinal therapy in treating children Henoch-Schonlein purpura (HSP) and its preventive effect on complicated renal impairment.</p><p><b>METHODS</b>One hundred and twenty children with HSP were equally randomized into two groups, the treated group and the control group. Both were treated with conventional Western medical therapy, but Sanhuang Qingxue Yin (SQY, a Chinese herbal drug) was given additionally to the treated group. Besides, a group consisted of 30 healthy children was set up as a normal control. Changes of symptoms, physical signs, routine urine, plasma endothelin-1 (ET-1) and urinary levels of beta2-microglobulin (beta2-MG), albumin (ALB) and immunoglobulin G (IgG) before and after treatment were observed, and the recurrence was monitored.</p><p><b>RESULTS</b>The cure rate and the total effective rate in the treated group were 80.0% and 98.3%, while those in the control group were 61.7% and 88.3%, showing significant differences between groups (P < 0.05); the disappearance time of clinical symptoms was shorter in the treated group than in the control group, also showing a significant difference (P < 0.01); after 1-month treatment, levels of plasma ET-1, and urinary beta2-MG, ALB and IgG were improved in the treated group, reaching the levels opproximate to those in the normal control (P > 0.05), significant difference was shown as compared with those in the control group and with those before treatment respectively (P < 0.01, P < 0.05). The recurrent rate was 13.33% in the treated group and 30.0% in the control group, and they were statistically different (P < 0.05).</p><p><b>CONCLUSION</b>The integrative medicinal therapy is good for treating HSP in children, it could not only obviously relieve clinical symptoms, shorten the illness course and reduce the recurrent rate, but also effectively prevent the occurrence of renal impairment.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Albuminuria , Drug Therapy, Combination , Drugs, Chinese Herbal , Therapeutic Uses , Endothelin-1 , Blood , Immunoglobulin G , Urine , Integrative Medicine , Kidney Diseases , Phytotherapy , IgA Vasculitis , Drug Therapy , beta 2-Microglobulin , Urine
5.
Chinese Medical Journal ; (24): 1772-1777, 2004.
Article in English | WPRIM | ID: wpr-257361

ABSTRACT

<p><b>BACKGROUND</b>Prehospital delay remains one of the main causes of reduced benefit of reperfusion therapy for patients with acute myocardial infarction (AMI). The largest proportion of prehospital delay involves the interval between the onset of symptoms and the decision to seek medical treatment. The purpose of this study was to examine the factors associated with the extent of care-seeking delay in Beijing for patients with AMI.</p><p><b>METHODS</b>A structured interview was conducted in 102 patients with AMI in eight hospitals in Beijing.</p><p><b>RESULTS</b>The mean decision time in patients with AMI was (204 +/- 43) minutes, and prehospital delay time was (311 +/- 54) minutes. Only 34% of patients sought medical care within one hour and a further 36% of patients presented to one of the eight hospitals within two hours after onset. Educational level, atypical presentation of AMI, and family members at the site where AMI occurred were associated with longer delay time in seeking medical assistance (P < 0.05, respectively), whereas the intensity of chest pain was inversely related to patients' delay time (P < 0.01). Patients who perceived their family relationship as good, attributed their symptoms to AMI origin, knew the time-dependent nature of reperfusion therapy, or used emergency medical service tended to seek medical care in a more rapid manner (P < 0.05, respectively).</p><p><b>CONCLUSIONS</b>Patients with AMI in Beijing delay seeking medical care to a great extent. Health education to increase the level of awareness of the target population at increased risk of AMI, including patients and their family members, is probably beneficial to reduce patients' care-seeking delay.</p>


Subject(s)
Female , Humans , Male , Cognition , Myocardial Infarction , Psychology , Therapeutics , Patient Acceptance of Health Care , Regression Analysis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL